Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) Leases (2023 - 2025)

Indivior Pharmaceuticals (INDV) has 3 years of Leases data on record, last reported at $26.0 million in Q4 2025.

  • For Q4 2025, Leases fell 33.33% year-over-year to $26.0 million; the TTM value through Dec 2025 reached $26.0 million, down 33.33%, while the annual FY2025 figure was $26.0 million, 33.33% down from the prior year.
  • Leases reached $26.0 million in Q4 2025 per INDV's latest filing, down from $30.0 million in the prior quarter.
  • Across five years, Leases topped out at $40.0 million in Q4 2023 and bottomed at $26.0 million in Q4 2025.
  • Average Leases over 3 years is $34.5 million, with a median of $36.0 million recorded in 2025.
  • Peak YoY movement for Leases: fell 2.5% in 2024, then plummeted 33.33% in 2025.
  • A 3-year view of Leases shows it stood at $40.0 million in 2023, then decreased by 2.5% to $39.0 million in 2024, then plummeted by 33.33% to $26.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $26.0 million in Q4 2025, $30.0 million in Q3 2025, and $35.0 million in Q2 2025.